Tumour-specific proline vulnerability uncovered by differential ribosome codon reading
Fabricio Loayza‐Puch(German Cancer Research Center), Reuven Agami(The Netherlands Cancer Institute), Jelle Zijlstra(The Netherlands Cancer Institute), Olaf van Tellingen(Dutch Cancer Society), Koos Rooijers(The Netherlands Cancer Institute), Joachim F. Oude Vrielink(The Netherlands Cancer Institute), Alejandro P. Ugalde(The Netherlands Cancer Institute), Axel Bex(The Royal Free Hospital), Levi C.M. Buil(Cancer Genomics Centre), Rui Lopes(Roche (Switzerland)), Pieter van Breugel(The Netherlands Cancer Institute), Ingrid Hofland(The Netherlands Cancer Institute), Jelle Wesseling(Leiden University Medical Center)
Cited by 287
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884